bpc 157 ind fda warning bpc-157 not approved for human use The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety fda warning bpc-157 not approved
Description
doi: 10.1152/ajpgi.00318.2005 35 MankertzJAmashehMKrugSMFrommAAmashehSHillenbrandBet al
If the B12 deficiency problem is taken care of as soon as possible, such diseases are not likely to develop further
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes Diana Trofimovitch 1 , Steven J Baumrucker 2 Curr Pain Headache Rep 2020 Aug 26;24(10):64
This is good news for quality and safety, but it does not mean the FDA has approved these peptides as safe and effective
